Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the copenhagen city heart study)

American Journal of Cardiology

Volumn 111, Issue 8, 2013, Pages 1139-1145

  Lindberg, Soren ^a,b   Mogelvang, Rasmus ^a,b   Pedersen, Sune H ^a,b   Bjerre, Mette ^c,d   Frystyk, Jan ^c,d   Flyvbjerg, Allan ^c,d   Galatius, Søren ^a,b   Jensen, Jan Skov ^a,b,e  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DENMARK; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS;

EID: 84875825142     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.12.043     Document Type: Article

References (30)

1. H. Staiger, O. Tschritter, J. Machann, C. Thamer, A. Fritsche, E. Maerker, F. Schick, H.U. Haring, and M. Stumvoll Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans Obes Res 11 2003 368 372
2. S.H. Han, I. Sakuma, E.K. Shin, and K.K. Koh Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies Prog Cardiovasc Dis 52 2009 126 140
3. H. Kato, H. Kashiwagi, M. Shiraga, S. Tadokoro, T. Kamae, H. Ujiie, S. Honda, S. Miyata, Y. Ijiri, J. Yamamoto, N. Maeda, T. Funahashi, Y. Kurata, I. Shimomura, Y. Tomiyama, and Y. Kanakura Adiponectin acts as an endogenous antithrombotic factor Arterioscler Thromb Vasc Biol 26 2006 224 230
4. Y. Cao, L. Tao, Y. Yuan, X. Jiao, W.B. Lau, Y. Wang, T. Christopher, B. Lopez, L. Chan, B. Goldstein, and X.L. Ma Endothelial dysfunction in adiponectin deficiency and its mechanisms involved J Mol Cell Cardiol 46 2009 413 419
5. Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, K. Sugimoto, Y. Fu, M. Motone, K. Yamamoto, A. Matsuo, K. Ohashi, S. Kihara, T. Funahashi, H. Rakugi, Y. Matsuzawa, and T. Ogihara Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 2004 1318 1323
6. R. Schnabel, C.M. Messow, E. Lubos, C. Espinola-Klein, H.J. Rupprecht, C. Bickel, C. Sinning, S. Tzikas, T. Keller, S. Genth-Zotz, K.J. Lackner, T.F. Munzel, and S. Blankenberg Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
7. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 29 2004 1730 1737
8. C. Forsblom, M.C. Thomas, J. Moran, M. Saraheimo, L. Thorn, J. Wadén, D. Gordin, J. Frystyk, and A. Flyvbjerg Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes J Intern Med 26 2011 1365 2796
9. W. Rathmann, and C. Herder Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology" Horm Metab Res 39 2007 1 2
10. R. Mogelvang, J.P. Goetze, P. Schnohr, P. Lange, P. Sogaard, J.F. Rehfeld, and J.S. Jensen Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide J Am Coll Cardiol 50 2007 1694 1701
11. M. Madsen, M. Davidsen, S. Rasmussen, S.Z. Abildstrom, and M. Osler The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry J Clin Epidemiol 56 2003 124 130
12. J. Frystyk, L. Tarnow, T.K. Hansen, H.H. Parving, and A. Flyvbjerg Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications Diabetologia 48 2005 1911 1918
13. G. Vervoort, J.M. Klein Gunnewiek, H.L. Willems, and J.F. Wetzels Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR Nephrol Dial Transplant 21 2006 2998 2999
14. Executive Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
15. A. Barseghian, D. Gawande, and M. Bajaj Adiponectin and vulnerable atherosclerotic plaques J Am Coll Cardiol 57 2011 761 770
16. S. Kojima, T. Funahashi, F. Otsuka, H. Maruyoshi, T. Yamashita, I. Kajiwara, H. Shimomura, Y. Miyao, K. Fujimoto, S. Sugiyama, T. Sakamoto, M. Yoshimura, and H. Ogawa Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction Atherosclerosis 194 2007 204 213
17. F. Otsuka, S. Sugiyama, S. Kojima, H. Maruyoshi, T. Funahashi, K. Matsui, T. Sakamoto, M. Yoshimura, K. Kimura, S. Umemura, and H. Ogawa Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease J Am Coll Cardiol 48 2006 1155 1162
18. T. Pischon, F.B. Hu, C.J. Girman, N. Rifai, J.E. Manson, K.M. Rexrode, and E.B. Rimm Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women Atherosclerosis 219 2011 322 329
19. M.B. Schulze, I. Shai, E.B. Rimm, T. Li, N. Rifai, and F.B. Hu Adiponectin and future coronary heart disease events among men with type 2 diabetes Diabetes 54 2005 534 539
20. J. Frystyk, C. Berne, L. Berglund, K. Jensevik, A. Flyvbjerg, and B. Zethelius Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men J Clin Endocrinol Metab 92 2007 571 576
21. R. Wolk, P. Berger, R.J. Lennon, E.S. Brilakis, D.E. Davison, and V.K. Somers Association between plasma adiponectin levels and unstable coronary syndromes Eur Heart J 28 2007 292 298
22. N. Sattar, G. Wannamethee, N. Sarwar, J. Tchernova, L. Cherry, A.M. Wallace, J. Danesh, and P.H. Whincup Adiponectin and coronary heart disease: a prospective study and meta-analysis Circulation 114 2006 623 629
23. S. Pilz, H. Mangge, B. Wellnitz, U. Seelhorst, B.R. Winkelmann, B. Tiran, B.O. Boehm, and W. Marz Adiponectin and mortality in patients undergoing coronary angiography J Clin Endocrinol Metab 91 2006 4277 4286
24. G.A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study Am J Epidemiol 165 2007 164 174
25. S. Lindberg, S.H. Pedersen, R. Mogelvang, M. Bjerre, J. Frystyk, A. Flyvbjerg, S. Galatius, and J.S. Jensen Usefulness of adiponectin as a predictor of all-cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol 109 2012 492 496
26. G. Maiolino, M. Cesari, D. Sticchi, M. Zanchetta, L. Pedon, K. Antezza, A.C. Pessina, and G.P. Rossi Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients J Clin Endocrinol Metab 93 2008 3333 3340
27. H. Kobayashi, N. Ouchi, S. Kihara, K. Walsh, M. Kumada, Y. Abe, T. Funahashi, and Y. Matsuzawa Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 2004 27 31
28. R.S. Khan, T.S. Kato, A. Chokshi, M. Chew, S. Yu, C. Wu, P. Singh, F.H. Cheema, H. Takayama, C. Harris, G. Reyes-Soffer, R. Knöll, H. Milting, Y. Naka, D. Mancini, and P.C. Schulze Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation Circ Heart Fail 5 2012 340 348
29. W. Yi, Y. Sun, E. Gao, X. Wei, W.B. Lau, Q. Zheng, Y. Wang, Y. Yuan, X. Wang, L. Tao, R. Li, W. Koch, and X.L. Ma Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms Antioxid Redox Signal 15 2011 1779 1788
30. K.L. Mullen, A.C. Smith, K.A. Junkin, and D.J. Dyck Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats Am J Physiol Endocrinol Metab 293 2007 83 90